RIO DE JANEIRO, BRAZIL - The maker of the West’s first Covid-19 vaccine is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage of shots and a rebound in infections.
The German company that joined with Pfizer to manufacture and distribute its vaccine, has marshaled an alliance of 13 companies, including Novartis, Merck KGaA and Sanofi, in an effort to meet—and perhaps exceed—an ambitious target of making 2 billion doses of vaccine this year.
The European Union has been struggling with a shortage of vaccines . . .